Company Overview
AC Immune SA (NASDAQ:ACIU) is a clinical stage biotech company headquartered in Lausanne, Switzerland, with a three-pillar approach to neurological disorders: Alzheimer’s disease, non-Alzheimer's disease/NeuroOrphans and diagnostics. Using our proprietary immunology (SupraAntigenTM) and chemistry (MorphomersTM) platforms,we develop innovative therapeutics with “best in class” potential in three areas: vaccines, antibodies and small molecules as well as diagnostics for PET imaging. Our approach has been validated by partnerships with companies such as Genentech, Janssen, Lilly and Life Molecular Imaging, and supported by the LuMind organization and Michael J.Fox Foundation